Ernexa Therapeutics Inc.: Form 10-K for the period ended Dec 31, 2011
Filed with the SEC on Mar 30, 2012 and accepted by EDGAR at Mar 30, 2012, 13:57 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2011-01-01 to 2011-12-31 | $23.9m | us-gaap:SalesRevenueNet |
| Selling, general and administrative | 12 months2011-01-01 to 2011-12-31 | $20.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2011-01-01 to 2011-12-31 | −$3.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2011-01-01 to 2011-12-31 | $52.0k | us-gaap:InterestExpense |
| Income tax | 12 months2011-01-01 to 2011-12-31 | $163.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2011-01-01 to 2011-12-31 | −$3.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2011-01-01 to 2011-12-31 | −$0.06 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2011-01-01 to 2011-12-31 | $574.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2011-01-01 to 2011-12-31 | $1.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2011-12-31 | $1.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-12-31 | $2.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2011-12-31 | $11.6m | us-gaap:Assets |
| Current liabilities | At period end2011-12-31 | $3.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2011-12-31 | $5.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2011-12-31 | $6.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001019687-12-001146. Last ingested by Listed: Nov 11, 2026, 02:49 ET. Listed shows no prices and gives no investment advice.